Market Research Logo

Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review

Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Eisai Co Ltd (Eisai) is a pharmaceutical company that undertakes the research, development, manufacture and marketing of pharmaceuticals, including over-the-counter (OTC) drugs, prescription medicines and generics. The company’s franchise areas in research include neurology and oncology. Eisai’s major products include Pariet/AcipHex (proton pump inhibitor); Aricept, an anti-Alzheimer's agent; Halaven, a novel anti-cancer agent; Fycompa, an anti-epileptic and peripheral neuropathy treatment, among others. Eisai has production plants in Japan, the UK, China and India and laboratories in Japan, the US and the UK; overseas sales offices in the US, Germany, France, China and South Korea. Eisai is headquartered in Tokyo, Japan.

Eisai Co Ltd Key Recent Developments

Jul 27,2018: AAIC 2018 introduces first clinical trial showing intensive blood pressure therapy reduces new cases of mild cognition and dementia
Jul 19,2018: PhoenixBio provides results from studies using PXB-Mouse and PXB-cells being presented at ISSX 2018
Jul 18,2018: Eisai supports relief efforts for flooding in western Japan
Jul 04,2018: Eisai Listed For 17th Consecutive Year In FTSE4GOOD Index Series, An Index For Socially Responsible Investment
Jun 13,2018: Eisai To Establish New Research Facility “Eisai Center For Genetics Guided Dementia Discovery” In Cambridge, Massachusetts In The United States

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Eisai Co Ltd - Key Facts
Eisai Co Ltd - Key Employees
Eisai Co Ltd - Key Employee Biographies
Eisai Co Ltd - Major Products and Services
Eisai Co Ltd - History
Eisai Co Ltd - Company Statement
Eisai Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Eisai Co Ltd - Business Description
Product Category: Neurology Products
Overview
Performance
Product Category: Oncology Products
Overview
Performance
Product Category: Others
Performance
Product Category: Americas Pharmaceutical Business
Overview
Performance
Product Category: Asia and Latin America Pharmaceutical Business
Overview
Performance
Product Category: China Pharmaceutical Business
Overview
Performance
Product Category: EMEA Pharmaceutical Business
Overview
Performance
Product Category: Japan Pharmaceutical Business
Overview
Performance
Product Category: Other Business
Overview
Performance
R&D Overview
Eisai Co Ltd - Corporate Strategy
Eisai Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Eisai Co Ltd - Strengths
Eisai Co Ltd - Weaknesses
Eisai Co Ltd - Opportunities
Eisai Co Ltd - Threats
Eisai Co Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Eisai Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 27, 2018: AAIC 2018 introduces first clinical trial showing intensive blood pressure therapy reduces new cases of mild cognition and dementia
Jul 19, 2018: PhoenixBio provides results from studies using PXB-Mouse and PXB-cells being presented at ISSX 2018
Jul 18, 2018: Eisai supports relief efforts for flooding in western Japan
Jul 04, 2018: Eisai Listed For 17th Consecutive Year In FTSE4GOOD Index Series, An Index For Socially Responsible Investment
Jun 13, 2018: Eisai To Establish New Research Facility “Eisai Center For Genetics Guided Dementia Discovery” In Cambridge, Massachusetts In The United States
Jun 13, 2018: Eisai To Establish New Research Facility “Eisai Center For Genetics Guided Dementia Discovery” In Cambridge, Massachusetts In The United States
Jun 13, 2018: Industry-Academia-Government Joint Development Agreement Concerning Nucleic Acid Drug Discovery Research Using Novel Nucleic Acid Synthesis And Delivery Technologies Concluded
Feb 26, 2018: Launch of Dementia Support Insurance to Provide for Dementia in Japan
Feb 20, 2018: EISAI Certified In 2018 As Outstanding Health And Productivity Management Organization (WHITE 500)
Feb 20, 2018: EISAI Certified In 2018 As Outstanding Health And Productivity Management Organization (WHITE 500)
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Eisai Co Ltd, Key Facts
Eisai Co Ltd, Key Employees
Eisai Co Ltd, Key Employee Biographies
Eisai Co Ltd, Major Products and Services
Eisai Co Ltd, History
Eisai Co Ltd, Subsidiaries
Eisai Co Ltd, Joint Venture
Eisai Co Ltd, Key Competitors
Eisai Co Ltd, Ratios based on current share price
Eisai Co Ltd, Annual Ratios
Eisai Co Ltd, Annual Ratios (Cont...1)
Eisai Co Ltd, Annual Ratios (Cont...2)
Eisai Co Ltd, Interim Ratios
Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Eisai Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Eisai Co Ltd, Performance Chart (2014 - 2018)
Eisai Co Ltd, Ratio Charts
Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report